< Back to all clusters
[HEALTH] · Brazil · 23 sources

started · updated

Brazil Ministry of Health expands SUS cancer drug offerings

The Brazilian Ministry of Health has begun offering nine new high-technology medications for cancer treatment through the Unified Health System (SUS). This expansion is intended to cover 100% of the demand for these specific products and is expected to benefit more than 116,000 patients.

The new medications address 13 different cancer indications, including treatments for breast, prostate, lung, and lymphoma cancers. Initial distribution is starting across 20 treatment centers in all regions of Brazil, with plans to expand to all remaining centers by the end of the year. The government aims to reach a total of 23 new oncological drugs by year-end, increasing public health treatment alternatives by 35%.

To facilitate this, the Ministry has assumed direct negotiation for ten drugs, coordinated price-reduction procurement for nine others, and increased funding for the remaining four. The annual cost for the acquisition of these nine new products is estimated at R$ 155.4 million, while the total impact of the broader expansion is estimated at R$ 4 billion per year.

Entities

Alexandre Padilha · Brazil · Hospital Beneficência Portuguesa · Hospital São Marcos · Ministry of Health · SUS

Claims

What the coverage asserts, and how many sources carry each claim.

Sources